The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Paclitaxel 6 mg/ml Concentrate for Solution for Infusion

Esteve Pharmaceuticals GmbHPA22709/004/001

Main Information

Trade NamePaclitaxel 6 mg/ml Concentrate for Solution for Infusion
Active SubstancesPaclitaxel
Dosage FormConcentrate for solution for infusion
Licence HolderEsteve Pharmaceuticals GmbH
Licence NumberPA22709/004/001

Group Information

ATC CodeL01CD Taxanes
L01CD01 paclitaxel


License statusWithdrawn
Withdrawn Date29/06/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back